510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Elia CCP, Model 14-5515-01; Elia CCP Control, Model 83-1009-01

K061165510(k) TraditionalCleared Aug 3, 200699-day reviewClass II21 CFR 866.5775Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sweden Diagnostics (Us), Inc. · NHX Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

Cleared on Aug 3, 2006 as substantially equivalent to K023285 (Axis-Shield Diagnostics, Ltd., 2002) after a 99-day review. Its family tree reaches back 1 generation to 2002. 1 later device descends from it. It has been recalled once.

Decided
Aug 3, 2006
Review
99 days
Class
Class II
Product code
NHX
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K023285 (2002). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2016: 1 descendant clearedK023285 · Diastat Anti Cyclic Citrullinated Peptide (Anti-CCP) Elisa · Axis-Shield Diagnostics, Ltd. · 2002 · recalled200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K023285 · Diastat Anti Cyclic Citrullinated Peptide (Anti-CCP) Elisa · Axis-Shield Diagnostics, Ltd. · 2002 · recalled0
  1. Root · 1 generation backK023285 Diastat Anti Cyclic Citrullinated Peptide (Anti-CCP) ElisaAxis-Shield Diagnostics, Ltd. · 2002 · Recalled
  2. This deviceK061165 Elia CCP, Model 14-5515-01; Elia CCP Control, Model 83-1009-01Sweden Diagnostics (Us), Inc. · 2006
  3. Descendant · cites it directly · 0 of its ownK151799 EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid…Phadia AB · 2016

Most influential descendants

Showing 1 of 1 · See all
  • K151799EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid Positive Control 250…Phadia AB · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K023285Diastat Anti Cyclic Citrullinated Peptide (Anti-CCP) ElisaAxis-Shield Diagnostics, Ltd.20021
0 (this device)K061165Elia CCP, Model 14-5515-01; Elia CCP Control, Model 83-1009-01Sweden Diagnostics (Us), Inc.2006—
+1K151799EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid Positive…Phadia AB2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K061165, 2002–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NHX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023285Diastat Anti Cyclic Citrullinated Peptide (Anti-CCP) Elisa
Summary page 1
…CCP Control NHX II 866.5775 Substantial Equivalence to Axis-Shield Diastat Anti-CCP 510(k) number: K023285 CONFIDENTIAL AND PROPRIETARY Page 64 EliATM CCP - New Device 510(…
Axis-Shield Diagnostics, Ltd.20021

Also cleared against K023285: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151799EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid Positive Control 250…Phadia AB20160

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 30, 2017Class IIZ-1253-2017Under Investigation by firmErroneous EliA test results related to problems with liquid level detection and diluent pipetting in Phadia 250 instruments, and deformed bottles. Investigation showed problems with the liquid level detection in diluent bottle batch JJCA…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K151799 (Phadia AB, 2016) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K023285.

How does its category compare?

All NHX devices

NHX Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NHX

1in 2016

2007: 22008: 22009: 22010: 32011: 22013: 12015: 12016: 1
2007high 3 (2010) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NHX

344in 2010

2010: 344 days median
2007high 344 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NHX

No recall names NHX since 2007.

Adverse event reports per year · NHX

3in 2025

2013: 22015: 42016: 42017: 12018: 42019: 132020: 32023: 62024: 42025: 3
2007high 13 (2019) · low 0 (2007)2025

MAUDE reports naming product code NHX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20092—00
2010334400
20112—00
20120—00
20131—02
20140—00
20151—04
20161—04
20170—01
20180—04
20190—013
20200—03
20210—00
20220—00
20230—06
20240—04
20250—03
20260—0—

What is it indicated for?

EliA CCP is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to cyclic citrullinated peptides (CCP) in human serum and plasma. The presence of anti-CCP antibodies can be used in conjunction with clinical findings and other laboratory tests as an aid in the clinical diagnosis of rheumatoid arthritis (RA). EliA CCP uses the EliA IgG method on the instruments ImmunoCAP 100 and ImmunoCAP 250.

EliA CCP Control is intended for laboratory use in monitoring the performance of in vitro measurement of anti-cyclic citrullinated peptide (CCP) antibodies with ImmunoCAP using the EliA IgG method.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061165: Elia CCP, Model 14-5515-01; Elia CCP Control, Model 83-1009-01.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061165

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026